Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2020-07-01
2021-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cold-atmospeheric pressure plasma activated solution
Treatment arm subjects receive the trial intervention
Cold-atmospeheric pressure plasma activated aqueous-alcohol solution treatment
Cold plasma is generated and applied to carrier liquid. Subjects are provided with the liquid to apply to the treated area
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cold-atmospeheric pressure plasma activated aqueous-alcohol solution treatment
Cold plasma is generated and applied to carrier liquid. Subjects are provided with the liquid to apply to the treated area
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability of applying treatment regularly
* ability to keep in-person follow-up appointments
Exclusion Criteria
* starting or discontinuing any hair loss treatments within 6 months of start date
* allergy to any components of the carrier solution
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Peter C. Friedman
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Peter C. Friedman
President
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Skin Center Dermatology Group
New City, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Khan A, Malik S, Walia J, Fridman G, Fridman A, Friedman PC. Tolerability of Six Months Indirect Cold (Physical) Plasma Treatment of the Scalp for Hair Loss. J Drugs Dermatol. 2020 Dec 1;19(12):1177-1180. doi: 10.36849/JDD.2020.5186.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20200501
Identifier Type: -
Identifier Source: org_study_id